Publications Repository - Gdańsk University of Technology

The purpose of this review article is to provide an overview of recent achievements in the synthesis of novel steroid sulfatase (STS) inhibitors. STS is a crucial enzyme in the biosynthesis of active hormones (including estrogens and androgens) and, therefore, represents an extremely attractive molecular target for the development of hormone-dependent cancer therapies. The inhibition of STS may effectively reduce the availability of active hormones for cancer cells, causing a positive therapeutic effect. Herein, we report examples of novel STS inhibitors based on steroidal and nonsteroidal cores that contain various functional groups (e.g., sulfamate and phosphorus moieties) and halogen atoms, which may potentially be used in therapies for hormone-dependent cancers. The presented work also includes examples of multitargeting agents with STS inhibitory activities. Furthermore, the fundamental discoveries in the development of the most promising drug candidates exhibiting STS inhibitory activities are highlighted.

Authors

• dr inż. Mateusz Daśko link open in new tab ,
• dr hab. inż. Sebastian Demkowicz link open in new tab ,
• dr inż. Karol Biernacki link open in new tab ,
• mgr inż. Olga Ciupak link open in new tab ,
• Witold Kozak,
• Maciej Masłyk,
• prof. dr hab. inż. Janusz Rachoń link open in new tab